• Aucun résultat trouvé

Varietal susceptibility of maize to larger grain borer, Prostephanus truncatus (Horn) (Coleoptera; Bostrichidae), based on grain physicochemical parameters

N/A
N/A
Protected

Academic year: 2021

Partager "Varietal susceptibility of maize to larger grain borer, Prostephanus truncatus (Horn) (Coleoptera; Bostrichidae), based on grain physicochemical parameters"

Copied!
16
0
0

Texte intégral

Loading

Figure

Fig 1. Number of F 1 P. truncatus progeny emerged on 60 g grains. Number of F 1 P. tuncatus progeny emerged on 60 g grains of each maize varieties after infestation out under no-choice method for 55 days on laboratory conditions
Table 1. Effect of nine maize varieties on duration of development, number of emerged F 1 progeny of P
Table 2. Parameters characteristic of maize sensitivity.
Table 4. Spearman correlation matrix between physical, biochemical and varietal susceptibility parameters.
+3

Références

Documents relatifs

„ ARTIFICIAL FEEDING: the infant is given breast- milk substitutes and not breastfeeding at all.. „ REPLACEMENT FEEDING: the process of feeding a child of an HIV-positive mother who

„ ARTIFICIAL FEEDING: the infant is given breast- milk substitutes and not breastfeeding at all.. „ REPLACEMENT FEEDING: the process of feeding a child of an HIV-positive mother who

Finally, as evidenced by the recent Canadian Society of Hospital Medicine document “Core Competencies in Hospital Medicine,” 2 inpatient physician care is highly focused on

Mortality is actually minimized with body mass in the high-normal or overweight range, and the safest body-mass trajectory is weight stabilization with no further gain and

2 Combination therapy using the different properties as well as chemical classes of oral hypoglycemic agents has broad pharmacodynamic appeal, as it allows us ways

Our results showed that the participants maintaining weight loss “struggled” more than the persons who spontaneously maintained a normal weight: the WLoMs followed more rigid

2016 Net Earnings from Continuing Operations, excluding Specified Items, excludes net after-tax charges of $2.012 billion, or $1.35 per share, for intangible amortization expense,

Lésions‐‐‐ symptômes‐‐‐ complication‐‐‐